SIDE EFFECTS The most common adverse events reported in clinical trials for Cagrilintide, both as monotherapy and as CagriSema, are primarily gastrointestinal (GI) in nature, typically classified as mild to moderate in severity
The SURMOUNT-4 trial showed average regain of 14 percent of body weight within one year after stopping
Recognizing the characteristic uptake associated with GLP-1 agonists helps avoid unnecessary anxiety and interventions, ensuring patients receive the right care, at the right time, without detours or doubt, Dr
Usually, the cause is a change in environment that your body registers as a shock, disturbing the hair cycle
Effects of long-term administration of LAC on rats increased dopamine production in the marginal division of the rat cortex and protective effects on acute stress exposure (96)
The 2026 GRAPPA Annual Meeting and Trainee Symposium runs from July 9 to 11 at the Corinthia Lisbon